Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viatris Inc. - Common Stock (NQ:VTRS)

13.86 -0.05 (-0.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,078,314
Open 13.93
Bid (Size) 13.70 (100)
Ask (Size) 14.00 (5,300)
Prev. Close 13.91
Today's Range 13.78 - 13.99
52wk Range 7.335 - 16.47
Shares Outstanding 1,212,301,241
Dividend Yield 3.46%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
A Fund Just Bet $5.7 Million on Robert Half -- Is the Staffing Sector Due for a Rebound? ↗
Robert Half Inc. provides staffing and risk consulting solutions globally to employers across diverse industries. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
QSM Asset Management Bets on Beaten-Down Manpower Group With New $5.9 Million Stake in ManpowerGroup ↗
ManpowerGroup provides staffing and HR solutions worldwide, serving clients in 75 countries. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+11.2%
+11.2%
1 Month
+2.6%
+2.6%
3 Month
+5.4%
+5.4%
6 Month
+38.9%
+38.9%
1 Year
+85.3%
+85.3%

More News

Read More
News headline image
What Investors Should Know About a $24 Million Exit From a Medical Device Stock Down 9% This Past Year ↗
Via The Motley Fool
Topics Regulatory Compliance
Viatris Inc (NASDAQ:VTRS) Beats Q4 2025 Estimates and Completes Strategic Review ↗
Via Chartmill
News headline image
1 Cash-Producing Stock to Target This Week and 2 That Underwhelm
Via StockStory
News headline image
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline ↗
Via The Motley Fool
News headline image
Viatris (VTRS): Buy, Sell, or Hold Post Q4 Earnings?
Via StockStory
Topics Stocks
News headline image
Viatris (VTRS): From Debt-Laden Merger to Specialty Powerhouse—A 2026 Research Deep Dive
Via Finterra
Topics Economy Initial Public Offering Retirement
News headline image
Spotting Winners: Viatris (NASDAQ:VTRS) And Generic Pharmaceuticals Stocks In Q4
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Bastion Bets on Government Spending with $8 Million New Stake in Parsons ↗
Via The Motley Fool
News headline image
The Pivot to Growth: Viatris (VTRS) Enters Phase 2 with 2026 Dividend and Capital Allocation Strategy
Via Finterra
Topics Economy
Wondering what's happening in today's S&P500 pre-market session? ↗
Via Chartmill
News headline image
Viatris (NASDAQ:VTRS) Posts Better-Than-Expected Sales In Q4 CY2025
Via StockStory
News headline image
Earnings To Watch: Viatris (VTRS) Reports Q4 Results Tomorrow
Via StockStory
Topics World Trade
News headline image
Supreme Court Strikes Down IEEPA Tariffs, Mandating Billions in Immediate Rebates
Via MarketMinute
Topics Bonds Economy Government
News headline image
1 Unpopular Stock That Should Get More Attention and 2 Facing Challenges
Via StockStory
News headline image
2 Value Stocks Worth Your Attention and 1 We Brush Off
Via StockStory
News headline image
Viatris at a Crossroads: Transitioning from Generic Giant to Specialty Powerhouse
Via Finterra
Topics Economy World Trade
News headline image
Why Viatris (VTRS) Stock Is Up Today
Via StockStory
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
Monday's pre-market session: top gainers and losers in the S&P500 index ↗
Via Chartmill
News headline image
3 Unprofitable Stocks with Questionable Fundamentals
Via StockStory
Topics Electric Vehicles
News headline image
3 Reasons to Sell VTRS and 1 Stock to Buy Instead
Via StockStory

Frequently Asked Questions

Is Viatris Inc. - Common Stock publicly traded?
Yes, Viatris Inc. - Common Stock is publicly traded.
What exchange does Viatris Inc. - Common Stock trade on?
Viatris Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viatris Inc. - Common Stock?
The ticker symbol for Viatris Inc. - Common Stock is VTRS on the Nasdaq Stock Market
What is the current price of Viatris Inc. - Common Stock?
The current price of Viatris Inc. - Common Stock is 13.86
When was Viatris Inc. - Common Stock last traded?
The last trade of Viatris Inc. - Common Stock was at 04/15/26 04:00 PM ET
What is the market capitalization of Viatris Inc. - Common Stock?
The market capitalization of Viatris Inc. - Common Stock is 16.80B
How many shares of Viatris Inc. - Common Stock are outstanding?
Viatris Inc. - Common Stock has 17B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.